Paper11250737
Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.
Clare SE and 2 others. Breast Cancer Res, 2000. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Papers, record 11250737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11250737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Breast Neoplasms | Major topic |
| Models, Biological | Major topic |
| Neoplasm Metastasis | Major topic |
| Algorithms | |
| Angiogenesis Inhibitors | |
| Cell Division | |
| Chemotherapy, Adjuvant | |
| Clinical Trials as Topic | |
| Combined Modality Therapy | |
| Disease Progression | |
| Drug Administration Schedule | |
| Drug Resistance, Neoplasm | |
| Female | |
| Humans | |
| Mastectomy | |
| Neoplasm Recurrence, Local | |
| Neovascularization, Pathologic | |
| Reproducibility of Results | |
| Stochastic Processes | |
| Time Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 11250732 | Molecular biology of breast cancer metastasis. 'Has it spread?': disarming one of the most terrifying questions. | https://conductscience.org/library/papers/11250732 |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8443754 | Mammographic assessment of human breast cancer growth and duration. | Cancer | 1993 | https://conductscience.org/library/papers/8443754 | PubMed |
| 2 | 7060033 | Rationale for the use of alternating non-cross-resistant chemotherapy. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/7060033 | PubMed |
| 3 | 9890174 | Dormancy of mammary carcinoma after mastectomy. | J Natl Cancer Inst | 1999 | https://conductscience.org/library/papers/9890174 | PubMed |
| 4 | 10200775 | Cancer statistics, 1999. | CA Cancer J Clin | 1999 | https://conductscience.org/library/papers/10200775 | PubMed |
| 5 | 8105098 | Report of the International Workshop on Screening for Breast Cancer. | J Natl Cancer Inst | 1993 | https://conductscience.org/library/papers/8105098 | PubMed |
| 6 | 1004590 | Predicting the course of Gompertzian growth. | Nature | 1976 | https://conductscience.org/library/papers/1004590 | PubMed |
| 7 | 1960555 | Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. | J Clin Oncol | 1991 | https://conductscience.org/library/papers/1960555 | PubMed |
| 8 | 3191483 | A Gompertzian model of human breast cancer growth. | Cancer Res | 1988 | https://conductscience.org/library/papers/3191483 | PubMed |
| 9 | 3510732 | The Norton-Simon hypothesis revisited. | Cancer Treat Rep | 1986 | https://conductscience.org/library/papers/3510732 | PubMed |
| 10 | 7585012 | Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. | Nat Med | 1995 | https://conductscience.org/library/papers/7585012 | PubMed |
| 11 | 7584949 | Angiogenesis in cancer, vascular, rheumatoid and other disease. | Nat Med | 1995 | https://conductscience.org/library/papers/7584949 | PubMed |
| 12 | 9342444 | Computer simulation of a breast cancer metastasis model. | Breast Cancer Res Treat | 1997 | https://conductscience.org/library/papers/9342444 | PubMed |
| 13 | 3828557 | On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future). | Bull Math Biol | 1986 | https://conductscience.org/library/papers/3828557 | PubMed |
| 14 | 49738 | The curability of breast cancer. | Lancet | 1975 | https://conductscience.org/library/papers/49738 | PubMed |
| 15 | 2259298 | Is Gompertzian or exponential kinetics a valid description of individual human cancer growth? | Med Hypotheses | 1990 | https://conductscience.org/library/papers/2259298 | PubMed |
| 16 | 6744323 | A stochastic numerical model of breast cancer growth that simulates clinical data. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744323 | PubMed |
| 17 | 8656257 | Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8656257 | PubMed |
| 18 | 1345869 | Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. | Lancet | 1992 | https://conductscience.org/library/papers/1345869 | PubMed |
| 19 | 8443753 | Decelerating growth and human breast cancer. | Cancer | 1993 | https://conductscience.org/library/papers/8443753 | PubMed |
| 20 | 526911 | A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/526911 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35487718 | Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35487718 | PubMed |
| 35103530 | Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening data. | Stat Methods Med Res | 2022 | https://conductscience.org/library/papers/35103530 | PubMed |
| 32825078 | A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32825078 | PubMed |
| 29979733 | Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS). | PLoS One | 2018 | https://conductscience.org/library/papers/29979733 | PubMed |
| 28406985 | Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. | PLoS One | 2017 | https://conductscience.org/library/papers/28406985 | PubMed |
| 25588472 | Modeling drug resistance in a conjoint normal-tumor setting. | Theor Biol Med Model | 2015 | https://conductscience.org/library/papers/25588472 | PubMed |
| 24491979 | Simplifying the complexity of resistance heterogeneity in metastasis. | Trends Mol Med | 2014 | https://conductscience.org/library/papers/24491979 | PubMed |
| 22387162 | The dynamics of drug resistance: a mathematical perspective. | Drug Resist Updat | 2012 | https://conductscience.org/library/papers/22387162 | PubMed |
| 21714780 | Bayesian enrichment strategies for randomized discontinuation trials. | Biometrics | 2012 | https://conductscience.org/library/papers/21714780 | PubMed |
| 21194536 | Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. | J Theor Biol | 2011 | https://conductscience.org/library/papers/21194536 | PubMed |
| 20205682 | Perspectives on tissue interactions in development and disease. | Curr Mol Med | 2010 | https://conductscience.org/library/papers/20205682 | PubMed |
| 19825370 | Mathematical modeling as a tool for planning anticancer therapy. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19825370 | PubMed |
| 15650642 | Modeling the effect of tumor size in early breast cancer. | Ann Surg | 2005 | https://conductscience.org/library/papers/15650642 | PubMed |
| 15642181 | Recent translational research: computational studies of breast cancer. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/15642181 | PubMed |
| 12479592 | Treatment of breast cancer with chemotherapy in combination with filgrastim: approaches to improving therapeutic outcome. | Drugs | 2002 | https://conductscience.org/library/papers/12479592 | PubMed |
| 11250732 | Molecular biology of breast cancer metastasis. 'Has it spread?': disarming one of the most terrifying questions. | Breast Cancer Res | 2000 | https://conductscience.org/library/papers/11250732 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11250737
GET https://conductscience.org/api/papers/v1/11250737/references?page=2